References
- Gasster M, Westwater JO, Molle WE. Use of a defoaming agent in gastroscopy. Gastroenterology 1954;27:652–5.
- Hirschowitz BI, Bolt RJ, Pollard MH. Defoaming in gastroscopy with silicone. Gastroenterology 1954;27:649–51.
- Dailey ME, Rider JA. Silicone anti-foam tablet in gastroscopy. JAMA 1954;155:859.
- Fujii T, Iishi H, Tatsuta M, Hirasawa R, Uedo N, Hifumi K, Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc 1998;47:382–7.
- Fujii T, Iishi H, Tatsuta M, Hirasawa R, Uedo N, Hifumi K, Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc 1998;47:382–7.
- Misumi A, Harada K, Murakami A, Arima K, Kondo H, Akagi M, Role of Lugol dye endoscopy in the diagnosis of early esophageal cancer. Endoscopy 1990;22:12–16.
- Fujita R, Yamamura H. Preparation of patients for gastroscopic examination. In: Takemoto T, editor. The manual of gastroenterological endoscopy. Tokyo: Nankodo; 1982.
- Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P, Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005;54:461–8.
- Tamura S, Ookawauchi K, Onishi S, Yokoyama Y, Yamada T, Higashidani Y, The usefulness of magnifying chromoendoscopy: pit pattern diagnosis can predict histopathological diagnosis precisely. Am J Gastroenterol 2002;97:2934–5.
- Kuo CH, Sheu BS, Kao AW, Wu CH, Chuang CH. A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy 2002;34:531–4.
- Yiengpruksawan A, Lightdale CJ, Gerdes H, Botet JF. Mucolytic-antifoam solution for reduction of artifacts during endoscopic ultrasonography: a randomized controlled trial. Gastrointest Endosc 1991;37:543–6.
- Kuo CH, Sheu BS, Kao AW, Wu CH, Chuang CH. A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy 2002;34:531–4.
- Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P, Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005;54:461–8.
- Denis-Ribeiro M, da Costa-Pereira A, Lopes C, Lara-Santos L, Guilherme M, Moreira-Dias L, Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia. Gastrointest Endosc 2003;57:498–504.
- Tamura S, Ookawauchi K, Onishi S, Yokoyama Y, Yamada T, Higashidani Y, The usefulness of magnifying chromoendoscopy: pit pattern diagnosis can predict histopathological diagnosis precisely. Am J Gastroenterol 2002;97:2934–5.
- Pathirana A, Poston GJ. Lessons from Japan––endoscopic management of early gastric and oesophageal cancer. Eur J Surg Oncol 2001;27:9–16.
- Banerjee B, Parker J, Waits W, Davis B. Effectiveness of preprocedure simethicone drink in improving visibility during esophagogastroduodenoscopy: a double-blind, randomized study. J Clin Gastroenterol 1992;15:264–5.
- Bertoni G, Gumina C, Conigliaro R, Ricci E, Staffetti J, Mortilla MG, Randomized placebo-controlled trial of oral liquid simethicone prior to upper gastrointestinal endoscopy. Endoscopy 1992;24:268–70.
- Fujii T, Iishi H, Tatsuta M, Hirasawa R, Uedo N, Hifumi K, Effectiveness of premedication with pronase for improving visibility during gastroendoscopy: a randomized controlled trial. Gastrointest Endosc 1998;47:382–7.
- Kuo CH, Sheu BS, Kao AW, Wu CH, Chuang CH. A defoaming agent should be used with pronase premedication to improve visibility in upper gastrointestinal endoscopy. Endoscopy 2002;34:531–4.
- Clarke AC, Chiragakis L, Hillman LC, Kaye GL. Sedation for endoscopy: the safe use of propofol by general practitioner sedationists. Med J Aust 2002;176:158–61.